Literature DB >> 4570455

Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity.

J Brod, L Horbach, H Just, J Rosenthal, R Nicolescu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4570455     DOI: 10.1007/bf00562506

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  18 in total

1.  NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS.

Authors:  R BOUCHER; R VEYRAT; J DE CHAMPLAIN; J GENEST
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

2.  Role of renin in acute postural homeostasis.

Authors:  S Oparil; C Vassaux; C A Sanders; E Haber
Journal:  Circulation       Date:  1970-01       Impact factor: 29.690

3.  [On the mechanism of action of a new antihypertensive substance with imidazoline structure].

Authors:  W Kobinger
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

4.  Improvement in methodology for measurement of plasma renin activity.

Authors:  R Boucher; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1966-01       Impact factor: 2.273

5.  [The behavior of hemodynamic values in hypertensive patients under treatment with dichlorophenylaminoimidazoline hydrochloride].

Authors:  H Pozenel
Journal:  Wien Klin Wochenschr       Date:  1969-03-14       Impact factor: 1.704

6.  Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres).

Authors:  J W Constantine; W K McShane
Journal:  Eur J Pharmacol       Date:  1968-09       Impact factor: 4.432

7.  [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].

Authors:  H Ludwig
Journal:  Arzneimittelforschung       Date:  1968-05

8.  Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery.

Authors:  R W Sattler; P A van Zwieten
Journal:  Eur J Pharmacol       Date:  1967-10       Impact factor: 4.432

9.  Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan).

Authors:  H Schmitt; H Schmitt
Journal:  Eur J Pharmacol       Date:  1969-04       Impact factor: 4.432

10.  Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (Catapresan, ST-155).

Authors:  G P Sherman; G J Grega; R J Woods; J P Buckley
Journal:  Eur J Pharmacol       Date:  1968-02       Impact factor: 4.432

View more
  7 in total

1.  [The effect of clonidine on renin-release (author's transl)].

Authors:  K A Meurer; G Kloos; A Helber; W Kaufmann
Journal:  Klin Wochenschr       Date:  1976-03-15

2.  Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors:  T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

Review 3.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.

Authors:  H H Parving; H Kastrup; U M Smidt; A R Andersen; B Feldt-Rasmussen; J S Christiansen
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

5.  Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.

Authors:  M Frisk-Holmberg; P O Edlund; L Paalzow
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

6.  The effect of clonidine on venous haemodynamics in cats and dogs.

Authors:  G A Bentley; L K Cullen; J A Reynoldson; R E Widdop
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

7.  Acute and chronic renal effects of guanfacine in essential and renal hypertension.

Authors:  A Roeckel; A Heidland
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.